The product was removed from refrigerated storage for an extended period of time.Recall Initiation Date: April 9, 2025Link: FDA Enforcement Report Facility Inspections FDA Warning Letters ProRx, LLC Type: Compounding pharmacy and FDA-registered outsourcing facilityFDA Department issuing Warning: Center for Drug Evaluation and Research (CDER)Warning Letter Date: January 15, 2025Facility Location: Exton, PennsylvaniaInspection Dates: July 15, 2024, to August 2, 2024
One condition concerns the bulk drug substance used to prepare the medication
Approaches like chemical peels, laser therapy, or topical lightening agents are designed for keratinized skin, not oral mucosa
AI has made it easier than ever for scammers to create convincing imitations, but with the right awareness and collaboration, it is still possible to stay ahead of them.
MG53, mitsugumin (or Tripartite motif containing 72, TRIM72)